Praxis Precision Medicines

Praxis Precision Medicines

PRAX· Manufacturing· Fiscal year ends in December

CEO pay in FY2025Stock +283.0% in FY2025

Marcio Souza is the CEO of Praxis Precision Medicines and was paid $8.7M in FY2025 (Dec), down 35%.

Pay$100 in the stock at the end of FY21 → $100
CEO pay is from each Praxis Precision Medicines proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Executives3

See all
  1. 1Marcio SouzaFY2025
  2. 2Timothy KellyFY2025
  3. 3Alex NemiroffFY2025

Named executives and their total pay, from the Summary Compensation Table of the latest proxy.

Pay

See all

Praxis Precision Medicines paid its 3 named executives $14.8M in total in FY2025 (Dec). CEO Marcio Souza was paid $8.7M of that.

Name
Marcio SouzaPresident and Chief Executive Officer
Timothy KellyChief Financial Officer
Alex NemiroffGeneral Counsel

of each named executive, from the Summary Compensation Table of each proxy.

Peers

No disclosed peer group

No proxy on file names a pay peer group for Praxis Precision Medicines. The peer group comes from the proxy statement, so it shows here when a proxy read has it.

Board6

See all
  • William YoungDirector · 9 yr on the boardIndependentCompensation (Chair), Nominating and Corporate Governance—Paid as an executive
  • Gregory NordenDirector · 6 yr on the boardIndependentAudit (Chair), Compensation—Paid as an executive
  • Jeffrey Chodakewitz, M.D.Director · 6 yr on the boardIndependentNominating and Corporate Governance (Chair), Science and Technology—Paid as an executive
  • Merit Cudkowicz, M.D.Director · 5 yr on the boardIndependentAudit, Science and Technology (Chair)—Paid as an executive
  • Jill DeSimoneDirector · 3 yr on the boardIndependentAudit, Nominating and Corporate Governance—Paid as an executive
  • Jeffrey KindlerDirector · -1 yr on the boardIndependentAudit, Nominating and Corporate Governance—Paid as an executive

The board of the latest proxy (FY2025).

Shared directors

Activity

  1. Pay
    Praxis Precision Medicines CFO pay fell 21% to $3.2M. The stock rose 283% in FY2025 (Dec).
    DEF 14A
  2. Pay
    Praxis Precision Medicines CEO pay fell 35% to $8.7M. The stock rose 283% in FY2025 (Dec).
    DEF 14A
  3. Pay
    Praxis Precision Medicines General counsel pay fell 27% to $2.8M. The stock rose 283% in FY2025 (Dec).
    DEF 14A
  4. Board
    Jeffrey Kindler joined the board of Praxis Precision Medicines. Jeffrey Kindler now sits on 5 public boards.
    3
  5. Pay
    Praxis Precision Medicines CFO pay rose 295% to $4.0M. The stock rose 245% in FY2024 (Dec).
    DEF 14A
  6. Pay
    Praxis Precision Medicines CEO pay rose 533% to $13.4M. The stock rose 245% in FY2024 (Dec).
    DEF 14A
  7. Pay
    Praxis Precision Medicines General counsel pay rose 365% to $3.9M. The stock rose 245% in FY2024 (Dec).
    DEF 14A
  8. Pay
    Praxis Precision Medicines CFO pay fell 56% to $1.0M. The stock fell 38% in FY2023 (Dec).
    DEF 14A
  9. Pay
    Praxis Precision Medicines CEO pay fell 65% to $2.1M. The stock fell 38% in FY2023 (Dec).
    DEF 14A

Filings6

See all
Proxy statementDEF 14AApr 30, 2026FY2025
Annual report10-KFeb 19, 2026FY2025
Proxy statementDEF 14AApr 30, 2025FY2024
Annual report10-KFeb 28, 2025FY2024
Proxy statementDEF 14AApr 26, 2024FY2023
Annual report10-KMar 5, 2024FY2023
For the press:Download CSVDownload PNGHow to use our data